Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.

Reynaud M, Aubin HJ, Trinquet F, Zakine B, Dano C, Dematteis M, Trojak B, Paille F, Detilleux M.

Alcohol Alcohol. 2017 Jul 1;52(4):439-446. doi: 10.1093/alcalc/agx030.

PMID:
28525555
2.

Acute impact of caffeinated alcoholic beverages on cognition: A systematic review.

Lalanne L, Lutz PE, Paille F.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:188-194. doi: 10.1016/j.pnpbp.2017.03.007. Epub 2017 Mar 19. Review.

PMID:
28330787
3.

Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.

Yéléhé-Okouma M, Martini H, Lemarié J, Labroca P, Petitpain N, Gibaja V, Paille F, Gillet P.

Fundam Clin Pharmacol. 2017 Oct;31(5):574-579. doi: 10.1111/fcp.12286. Epub 2017 May 9.

PMID:
28322465
4.

The 2015 French guidelines on alcohol misuse, issued in partnership with the European Federation of Addiction Societies: a focus on children and adolescents.

Rolland B, Paille F, Mann K, Aubin HJ.

Eur Child Adolesc Psychiatry. 2016 Oct;25(10):1145-8. doi: 10.1007/s00787-016-0874-x. Epub 2016 May 30. No abstract available.

PMID:
27240598
5.

A Point-by-Point Response to Braillon.

Rolland B, Paille F, Gillet C, Rigaud A, Moirand R, Dano C, Dematteis M, Mann K, Aubin HJ.

CNS Neurosci Ther. 2016 Jun;22(6):537-8. doi: 10.1111/cns.12565. No abstract available.

PMID:
27177736
6.

Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.

Rolland B, Paille F, Gillet C, Rigaud A, Moirand R, Dano C, Dematteis M, Mann K, Aubin HJ.

CNS Neurosci Ther. 2016 Jan;22(1):25-37. doi: 10.1111/cns.12489.

7.

Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: the Alcohol Quality of Life Scale (AQoLS).

Luquiens A, Whalley D, Laramée P, Falissard B, Kostogianni N, Rehm J, Manthey J, Paille F, Aubin HJ.

Qual Life Res. 2016 Jun;25(6):1549-60. doi: 10.1007/s11136-015-1190-5. Epub 2015 Nov 20.

PMID:
26589528
8.

Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.

Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S; GuidAge study group.

J Alzheimers Dis. 2015;48(3):793-804. doi: 10.3233/JAD-150013.

PMID:
26402073
9.

[Addiction to alcohol].

Paille F, Moirand R.

Rev Prat. 2015 Jun;65(6):859-68. French. No abstract available.

PMID:
26298919
10.

[Realities of alcohol withdrawal].

Paille F, Moirand R.

Rev Prat. 2015 Jun;65(6):845-6. French. No abstract available.

PMID:
26298916
11.

The New French Guidelines on Alcohol Misuse: An Initiative for Strengthening Cross-European Interplay.

Rolland B, Mann K, Paille F, Aubin HJ.

Addiction. 2015 Aug;110(8):1362-3. doi: 10.1111/add.12997. No abstract available.

PMID:
26173162
12.

People with alcohol use disorders in specialized care in eight different European countries.

Rehm J, Allamani A, Aubin HJ, Della Vedova R, Elekes Z, Frick U, Jakubczyk A, Kostogianni N, Landsmane I, Manthey J, Miquel L, Paille F, Pieper L, Probst C, Scafuri F, Shield KD, Snikere S, Struzzo P, Trapencieris M, Voller F, Wittchen HU, Gual A, Wojnar M.

Alcohol Alcohol. 2015 May;50(3):310-8. doi: 10.1093/alcalc/agv009. Epub 2015 Feb 25.

PMID:
25716113
13.

Nalmefene: a new approach to the treatment of alcohol dependence.

Paille F, Martini H.

Subst Abuse Rehabil. 2014 Aug 8;5:87-94. doi: 10.2147/SAR.S45666. eCollection 2014. Review. Erratum in: Subst Abuse Rehabil. 2015;6:81.

14.

Cognitive impairments in alcohol-dependent subjects.

Bernardin F, Maheut-Bosser A, Paille F.

Front Psychiatry. 2014 Jul 16;5:78. doi: 10.3389/fpsyt.2014.00078. eCollection 2014. Review.

15.

Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey.

Rolland B, Paille F, Fleury B, Cottencin O, Benyamina A, Aubin HJ.

PLoS One. 2014 Jun 2;9(6):e98062. doi: 10.1371/journal.pone.0098062. eCollection 2014.

16.

[Cognitive impairment of alcohol-dependent subjects].

Bernardin F, Maheut-Bosser A, Paille F.

Rev Prat. 2014 Apr;64(4):462-5. French.

PMID:
24855773
17.

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.

PMID:
23562264
18.

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.

Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S; GuidAge Study Group.

Lancet Neurol. 2012 Oct;11(10):851-9. doi: 10.1016/S1474-4422(12)70206-5. Epub 2012 Sep 6. Review.

PMID:
22959217
19.

[Misuse of alcohol and new drug treatments].

Paille F.

Rev Prat. 2011 Dec;61(10):1386-91. French.

PMID:
22288352
20.

GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.

Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B; GuidAge study GROUP.

Curr Alzheimer Res. 2008 Aug;5(4):406-15.

PMID:
18690838

Supplemental Content

Loading ...
Support Center